Loading data for QNTM — first visit, this takes a few seconds.
Quantum BioPharma Ltd. (QNTM)
NasdaqCM: QNTM
· Real-Time Price · USD
2.98
-0.10 (-3.25%)
At close: Sep 03, 2026, 2:33 PM
The price, the headline numbers and the latest news, in one place.
Quantum BioPharma Ltd. (QNTM) Stock Price, Analysis & Data
-3.41% (1D)
| Bid | 2.22 |
| Market Cap | 19.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.2M |
| 0.43 | |
| -4.49 | |
| n/a | |
| -0.38 | |
| P/B (ttm) | 2.84 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 3.78 |
| Volume | 98,015 |
| Avg. Volume (20D) | 196,396 |
| Open | 3.10 |
| Previous Close | 3.08 |
| Day's Range | 2.91 - 3.19 |
| 52-Week Range | 2.07 - 21.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About QNTM
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead ...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 8, 2018
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol QNTM
Website https://www.quantumbiopharma.com
Financial Performance
In 2025, Quantum BioPharma's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -26.18M, an increase of 84.3%.
Financial StatementsEarnings Surprise
Quantum BioPharma has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.